The fatty liver that turns up in fit, busy professionals.
Fatty liver is usually pictured as a weight problem. A large share of the people who have it are not overweight, and plenty of them train well and look the part. The early signs often sit on a routine blood test, inside the printed range.
Yes, you can have a fatty liver at a normal weight. In a review of 93 studies covering more than 10 million people, about 1 in 5 people with fatty liver were lean and 4 in 10 were not obese.1 The condition is now called MASLD, short for metabolic dysfunction-associated steatotic liver disease. It is defined by fat in the liver plus at least one sign of metabolic strain, such as raised blood sugar, blood pressure or triglycerides. Body weight is not part of the definition.3
One of the first clues is often a liver enzyme called ALT creeping upward while it stays inside the lab’s normal range. Studies of healthy people suggest a truly healthy ALT sits lower than many printed upper limits,5 so a result can read “normal” and still be worth a second look, especially when it is higher than last year’s.
Across 93 studies, about 1 in 5 people with fatty liver were lean, and 4 in 10 were not obese.
An estimated 5.5 million Australians had fatty liver disease in 2019, projected to reach about 7 million by 2030.
In studies of healthy people, the upper limit for ALT came out at about 30 U/L for men and 19 U/L for women, lower than many printed lab limits.
In more than 142,000 adults followed for eight years, the risk of dying from liver disease rose with ALT even inside the normal range.
Fatty liver is linked to a 45% higher risk of heart attack and stroke, independent of age, weight and diabetes.
Fatty liver isn’t only a weight problem.
Most people picture fatty liver as something that happens to people carrying a lot of extra weight. That picture is out of date. When researchers pooled 93 studies from 24 countries, 19% of people with fatty liver were lean and 41% were not obese. In the general population, about 5% of people had fatty liver while sitting at a lean body weight.1
The American Gastroenterological Association now treats this as its own clinical picture. Its expert review estimates that 7 to 20% of people with fatty liver have a lean build, and notes that in lean people the condition is still linked to higher cardiovascular, liver and overall mortality than in people without it.2
The scale is the problem. It measures total weight. It does not measure where fat is stored, or how hard the body is working to handle the fuel it takes in. The liver stores fat when more comes in than it can burn or send out, and that can happen at any body size.
The new name says it outright. Under the 2023 definition, a person of normal weight with fat in the liver and one metabolic marker out of line, such as slightly raised triglycerides or blood sugar, meets the criteria.3 In Australia the condition was estimated to affect about 5.5 million people in 2019, a number projected to rise by a quarter by 2030.4
It’s a pattern I see often in senior roles: training four mornings a week, a sensible weight, and a calendar that ends most nights at a restaurant table. The training shows up in the mirror. The calendar tends to show up in the liver first.
An ALT drifting up inside the normal range is a trend.
ALT (alanine aminotransferase) is an enzyme that lives mostly inside liver cells. When those cells are under strain, more of it leaks into the blood. It is on almost every standard blood panel, which makes it one of the cheapest early signals you have.
The catch is where the line is drawn. A study of 6,835 first-time blood donors in Milan worked out healthy ALT ranges from the people at lowest risk of liver disease. The upper limits came out at about 30 U/L for men and 19 U/L for women, well below the limits in use at the time.5 The American College of Gastroenterology’s guideline puts a truly healthy ALT at 29 to 33 U/L for men and 19 to 25 U/L for women, and says levels above that should be looked into.6 Many lab reports still print a higher upper limit, so a result can sit above the healthy band and still carry no flag.
Does that gap matter? A Korean study followed more than 142,000 adults aged 35 to 59 for eight years. Compared with an ALT under 20, men with an ALT of 20 to 29 had about three times the risk of dying from liver disease, and men at 30 to 39 had more than nine times the risk. All of those results were inside the normal range of the day.7 Liver deaths are uncommon, so these are large ratios on a small base. The useful part is the direction: risk was already climbing well before the flag.
A normal ALT also doesn’t rule out a liver under real strain. In 458 people with fatty liver who had a liver biopsy, the more active inflammatory form was found in 59% of those whose ALT was normal, against 74% of those whose ALT was raised.8
So the most useful way to read ALT is as a line, not a dot. A move from 18 to 34 over three years says more than either number does alone, even though both would print as normal on most reports. It is also worth reading next to the markers that travel with it, listed in the table below.
A normal result tells you where you are. It doesn’t tell you which way you’re heading.
What to read alongside ALT.
No single marker diagnoses a fatty liver. Read together, and compared with your own earlier results, these show whether the liver is under more load than it used to be.
| Marker | What it shows | Why it matters here |
|---|---|---|
| ALT | Strain on liver cells | The trend across years matters more than the flag |
| GGT | Liver workload, including from alcohol | Often rises alongside ALT when the liver is busy |
| Triglycerides | Fat the liver is packaging and sending out | One of the five metabolic markers in the MASLD definition |
| Fasting insulin | How hard the body works to manage blood sugar | Can rise years before fasting glucose does |
| HbA1c | Average blood sugar over about three months | A slow upward creep is easy to miss without an earlier result |
| Liver imaging | Fat in the liver and how stiff it is | How a fatty liver is actually confirmed and staged |
What a full calendar asks of your liver.
Client dinners, functions, working lunches, late flights. None of it looks like a health problem on its own, and most of it is part of doing the job well. The liver doesn’t get a lighter week because the diary is full, though. It processes every drink and every late meal on top of everything else.
Alcohol is the obvious one, and the amounts that matter are smaller than most people assume. In a study of 285 people with fatty liver who had two liver biopsies about four years apart, those who drank modestly, up to two drinks a day, saw less improvement in liver fat than those who didn’t drink. They also had about a third of the odds of seeing the inflammatory form of the condition settle.9 Two drinks on a function night is an ordinary week for plenty of senior leaders. The 2023 definition even created a separate category for people with fatty liver whose drinking sits above that level.3
Sleep plays a part too. In 69,463 middle-aged workers and their spouses, sleeping five hours or less was linked with a higher chance of fatty liver on ultrasound than sleeping more than seven, and poor sleep quality carried a smaller extra risk. In men the link with short sleep faded once body weight was accounted for. In women it held.10 This kind of study shows a link, not cause and effect, but it fits with the wider evidence that short sleep unsettles metabolism. If late nights are a pattern, what deep sleep does for recovery covers that side.
Timing matters in a quieter way. The liver runs on a daily clock, handling fat and sugar differently depending on the time of day, and when you eat is one of the signals that sets that clock.11 The human evidence on meal timing by itself is still thin, and the total load counts most. But a pattern of large, late, wine-heavy dinners asks the liver to do its heaviest work at the time it is least set up for it.
November and December are the busiest stretch of the year for most calendars. That makes now a sensible time to know your starting numbers, before the season begins rather than after it.
The liver is an early signal for the heart.
Fat in the liver is rarely just a liver story. A pooled analysis of 36 studies covering 5.8 million middle-aged adults found that fatty liver was linked to a 45% higher risk of fatal or non-fatal cardiovascular events such as heart attack and stroke. In people whose liver had begun to scar, the risk was about two and a half times higher. Both findings held after accounting for age, sex, body weight, diabetes and other common risk factors.12
That is the reason to pay attention, and also the reason not to panic. Liver fat is one of the more changeable things in the body. In the alcohol study above, liver fat improved most over four years in the people who didn’t drink.9 The aim is to catch the drift while it is still a trend on a page, not a diagnosis.
The liver is also one of several organs that can age at a different pace from the rest of you, which is covered in why your organs age at different rates. For the full picture of what a well-year assessment should cover, see what an executive health check should measure.
Normal range.
Still worth reading →
The trend across years tells you more than any single result.
What the liver data actually says.
About 1 in 5 people with fatty liver are lean, so a normal weight does not rule it out.
Fatty liver is now called MASLD and is defined by liver fat plus a metabolic marker out of line, not by body size.
A healthy ALT sits at about 30 U/L or below for men and 19 to 25 U/L for women, lower than many printed lab limits.
Liver-related risk rises with ALT even inside the normal range, so the trend across years matters more than the flag.
Modest regular drinking, short sleep and late heavy meals all add to the liver’s load, and all are common in a full working calendar.
Frequently asked.
Can you have a fatty liver at a normal weight?
Yes. A review of 93 studies found about 1 in 5 people with fatty liver were lean and 4 in 10 were not obese. The current definition, MASLD, is based on fat in the liver plus at least one metabolic marker out of line, not on body weight.
What ALT level is considered healthy?
Studies of healthy people put the upper limit at about 30 U/L for men and 19 U/L for women, and the American College of Gastroenterology uses 29 to 33 U/L for men and 19 to 25 U/L for women. Many lab reports print a higher upper limit, so a result can be above the healthy band without a flag.
Is fatty liver serious if my ALT is normal?
A normal ALT does not rule it out. In one study of people with fatty liver who had a biopsy, the more active inflammatory form was found in 59% of those whose ALT was normal. A rising ALT across several years, read alongside GGT, triglycerides, fasting insulin and HbA1c, is more informative than one result.
Does drinking at work functions affect the liver?
It can. In people with fatty liver followed over about four years, those drinking up to two drinks a day saw less improvement in liver fat than those who didn’t drink, and were less likely to see liver inflammation settle.
How is fatty liver confirmed?
Blood tests point to it, but imaging confirms it. An ultrasound shows fat in the liver, and elastography measures how stiff the liver is, which shows whether any scarring has begun.
Know your numbers before the season.
A structured protocol built on comprehensive testing, then measured year on year against your own baseline. Telehealth, Australia-wide.
Book a discovery callReferences.
- Ye Q, Zou B, Yeo YH, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(8):739–752. doi.org/10.1016/S2468-1253(20)30077-7
- Long MT, Noureddin M, Lim JK. AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review. Gastroenterology. 2022;163(3):764–774.e1. doi.org/10.1053/j.gastro.2022.06.023
- Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542–1556. doi.org/10.1016/j.jhep.2023.06.003
- Adams LA, Roberts SK, Strasser SI, et al. Nonalcoholic fatty liver disease burden: Australia, 2019–2030. J Gastroenterol Hepatol. 2020;35(9):1628–1635. doi.org/10.1111/jgh.15009
- Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137(1):1–10. doi.org/10.7326/0003-4819-137-1-200207020-00006
- Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2017;112(1):18–35. doi.org/10.1038/ajg.2016.517
- Kim HC, Nam CM, Jee SH, et al. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ. 2004;328(7446):983. doi.org/10.1136/bmj.38050.593634.63
- Fracanzani AL, Valenti L, Bugianesi E, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology. 2008;48(3):792–798. doi.org/10.1002/hep.22429
- Ajmera V, Belt P, Wilson LA, et al. Among patients with nonalcoholic fatty liver disease, modest alcohol use is associated with less improvement in histologic steatosis and steatohepatitis. Clin Gastroenterol Hepatol. 2018;16(9):1511–1520.e5. doi.org/10.1016/j.cgh.2018.01.026
- Kim CW, Yun KE, Jung HS, et al. Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses. J Hepatol. 2013;59(2):351–357. doi.org/10.1016/j.jhep.2013.03.035
- McCommis KS, Butler AA. The importance of keeping time in the liver. Endocrinology. 2021;162(2):bqaa230. doi.org/10.1210/endocr/bqaa230
- Mantovani A, Csermely A, Petracca G, et al. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(11):903–913. doi.org/10.1016/S2468-1253(21)00308-3